At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM)：A Randomized, Double-blinded, Placebo-controlled, Multi-center Trial
In Brief
A Phase 4 clinical trial evaluating Pentoxifylline sustained-release tablets and Pentoxifylline sustained-release tablets placebo for Cerebral Small Vessel Diseases. Targeting 80 participants across 1 site.
Detailed Summary
This is a randomized, double-blinded, placebo-controlled, multi-center trial. Cerebral small vessel disease (CSVD) patients will be diagnosed according to STRIVE standards and randomized into the Pentoxifylline sustained-release tablet group and placebo group. The purpose of this trial is to assess the efficacy of Pentoxifylline sustained- release tablets on CSVD.
Study Details
Timeline
Interventions
a dose of 1 tablet twice a day of Pentoxifylline sustained-release tablets
Pentoxifylline sustained-release tablets placebo will be administrated at the same dosage and frequency as the experimental group